Skip to content

Platelet-Rich Plasma Combined with Strengthening Exercise in Knee Osteoarthritis

Effect of Platelet-Rich Plasma Combined with Supervised Strengthening Exercise on Pain in Knee Osteoarthritis - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/11/097165
Enrollment
120
Registered
2025-11-11
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M171- Unilateral primary osteoarthritisof knee

Interventions

Intervention1: Experimental group: Platelet-Rich Plasma + Supervised Strengthening Exercise Program: Participants in this group will receive three intra-articular PRP injections at weekly intervals (W

Sponsors

Sree Pallob
Lead Sponsor
Jashore University of Science and Technology Jashore Bangladesh
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Participants aged fifty years or older with a clinical diagnosis of knee osteoarthritis for at least six months according to the American College of Rheumatology criteria will be included. Eligible individuals must report an average knee pain score of four or higher on an eleven-point numerical rating scale over the past week and show mild to moderate radiographic tibiofemoral osteoarthritis defined as Kellgren and Lawrence grade two or three. All participants must provide informed consent and agree to participate in the eight-week study intervention.

Exclusion criteria

Exclusion criteria: Participants will be excluded if they show greater lateral than medial joint space narrowing on radiographs. Other exclusion criteria include the presence of systemic or inflammatory diseases, a history of glucocorticoid injection within the past three months, hyaluronic acid injection within the past six months, previous treatment with autologous blood products or stem cell therapy, platelet count one hundred fifty thousand per microliter or lower, bleeding disorders, or ongoing anticoagulant therapy. For bilateral knee osteoarthritis, only the most symptomatic knee will be treated.

Design outcomes

Primary

MeasureTime frame
Measure pain using the Numeric Pain Rating Scale (NPRS)Timepoint: At baseline, 8 weeks and 6 months

Secondary

MeasureTime frame
functional performance using the WOMAC index, range of motion by Goniometer, measure lower limb muscle strength through Hand held digital dynamometer and functional mobility with the Timed Up and Go (TUG).Timepoint: At baseline, 8 weeks and 6 months

Countries

Bangladesh

Contacts

Public ContactDr Md Zahid Hossain

Jashore University of Science and Technology

mz.hossain@just.edu.bd01670962775

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026